Viewing Study NCT00959959

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:45 PM
Ignite Modification Date: 2026-02-06 @ 3:13 AM
Study NCT ID: NCT00959959
Status: COMPLETED
Last Update Posted: 2020-09-04
First Post: 2009-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer
Sponsor: LTN PHARMACEUTICALS, INC.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CRPC View
None HRPC View
None TOK-001 View
None ARMOR View
None ARMOR1 View
None ESL View
None Galeterone View